美股A股
StockGist
Back
8-K2026-04-02· deepseek-chat

TCRX · TScan Therapeutics, Inc.

0001193125-26-138973

SEC filing

Summary

TScan Therapeutics announced the resignation of Vice President of Finance Leiden Dworak and the appointment of CFO Jason A. Amello as principal accounting officer, effective April 10, 2026.

Key takeaways